Radiance and dark spots
Skin brightening: risks, uneven tone and cosmetic care

Rejecting promises of rapid bleaching
Wanting a more even-looking complexion does not justify products of uncertain origin that promise rapid skin bleaching. The FDA warns about certain lightening products containing mercury or hydroquinone sold without authorisation in the United States. Legal frameworks differ between countries; the practical lesson is to verify ingredients, traceability and the legitimacy of the supply channel.
Addressing unevenness without changing skin identity
A radiance range can address the appearance of the complexion without treating every cause of pigmentation. New, changing or concerning marks deserve professional assessment before a cosmetic approach is chosen. Compare the actual stated objectives and precautions of a product instead of seeking a skin colour marketed as an ideal to be achieved.
Resources to explore further
FDA
The FDA warning explains risks associated with certain mercury or hydroquinone lighteners and identifies the United States regulatory context.Guerlain
Guerlain’s radiance-focused skincare makes it possible to distinguish the brand’s cosmetic claims from promises of radical skin bleaching.American Academy of Dermatology
AAD dermatologists explain limitations and precautions for retinoids, ingredients sometimes discussed in connection with the appearance of uneven tone.